Nectar Lifesciences

Nectar Lifesciences Limited
Public
Traded as BSE: 532649
NSE: NECLIFE
Industry Pharmaceuticals
Founded 1995
Headquarters Chandigarh, India
Key people
  • Sanjiv Goyal (Chairman)
  • Dinesh Dua (CEO)
  • Sandeep Goel (CFO)
  • Sunder Lal (Company secretary)
Products Pharmaceuticals,
Revenue Increase ₹ 16.4 billion
Increase ₹ 1.05 billion
Number of employees
 2200
Website www.neclife.com
Nectar Lifesciences Finished Dosage facility

Nectar Lifesciences Limited is a pharmaceutical company in India that manufactures generic drug products.[1] The company has global leadership in several oral and sterile cephalosporin drugs, and has cGMP facilities along with those approved by the European Union and Japan.[2]

History

The company was founded by Mr Sanjiv Goyal and was incorporated in June 1995. The company went public in July 2005 with simultaneous listings on the Bombay Stock Exchange and the National Stock Exchange of India. In 2010 New Silk Route Private Equity invested INR 2.5 billion in the company.

Management

Board of Directors: [3]

  • Chairman & Managing Director: Sanjiv Goyal
  • CEO & Director: Dinesh Dua

Market Cap

The current market capitalization is about INR 806.22 cr.[4]

Products

Nectar Lifesciences manufactures oral and sterile active pharmaceutical ingredients, finished dosages and phytochemicals. The company is also in the business of providing pharmaceutical organizations with contract research and manufacturing services. It also manufactures empty hard gelatin capsules.

References

  1. ↑ "NECTAR LIFESCIENCES LTD (NECLIFE:National Stock Exchange of India): Stock Quote & Company Profile - Businessweek". investing.businessweek.com. Retrieved 28 September 2012.
  2. ↑ "Nectar Lifesciences Limited (Neclife) Receives Anvisa Approval For Its Cephalosporin API's Manufacturing Facility". Institute of Good Manufacturing Practices India. Retrieved 1 July 2018.
  3. ↑ "Stock Quote News - Stock Market Quotes, Online Stock Quotes, India". in.reuters.com. Retrieved 28 September 2012.
  4. ↑ "Nectar Lifesciences". Money Control. Money Control. Retrieved 18 October 2016.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.